Alison Stopeck

Associate Director, Clinical and Translational Research, Stony Brook Cancer Center · Stony Brook Medicine

Credentials: · · · · ·

History

Three-Arm Randomized Trial Comparing the Effect of Aspirin, Sulindac or No Treatment Control on Breast Density in Patients with Elevated Breast Cancer Risk
National Cancer Institute · R01
PI · $3M · State University New York Stony Brook
2019–2026
Nsaid Effects on Clinical and Imaging Breast Biomarkers
National Cancer Institute · R01
Contact PI · $2.4M · State University New York Stony Brook
2012–2019
Diffusion Mri as Biomarker for Therapy Response in Breast Cancer Metastases
National Cancer Institute · R01
Contact PI · $1.7M · University of Arizona
2006–2013
Diffusion Mri and Chemotherapeutic Response
National Cancer Institute · R21
Contact PI · $303K · University of Arizona
2000–2003

Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
Principal investigator · Recruiting · Early phase 1
Alison Stopeck
2024–2026
Sulindac and Breast Density in Women at Risk of Developing Breast Cancer
Principal investigator · Completed · Phase 2
Alison Stopeck
2020–2025
Denosumab and MRI Breast Imaging
Principal investigator · Completed · Phase 2
Alison Stopeck
2015–2021
NSAID Effects on Clinical and Imaging Breast Biomarkers
Principal investigator · Completed · Phase 2
Stony Brook University
2012–2019